Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3759studies shown
Showing 229-240 of 3,759
Drug study icon
RecruitingNCT07263191

Olanzapine in people with Bipolarity.

This study is recruiting in South Korea. It is testing olanzapine for Bipolarity.

In Seongnam
BipolarityDrugA study involving a medication or substance.Over 19 Years
Countries
South Korea
Sponsor
Boryung Pharmaceutical Co., Ltd
Condition
Bipolarity
Behavioral study icon
RecruitingISRCTN16493616

Resilience training for student paramedics

This study is recruiting in the United Kingdom. It is testing resilience training for Depression.

In United Kingdom
DepressionOtherFrom 18 Years to 120 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
Drug study icon
RecruitingNCT07615426

Aticaprant for schizophrenia

This study is recruiting in the United States. It is testing aticaprant for schizophrenia.

Multiple locations, including Garden Grove
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN58916738

The impact on wellbeing of HS2

This study is recruiting in the United Kingdom. It focuses on Mental health.

In United Kingdom
Mental healthOtherOver 18 Years
Countries
United Kingdom
Sponsor
RAND Europe
Condition
Mental health
Drug study icon
RecruitingNCT06657430

A Study on the Preference of Risperidone Dosage Forms

This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.

In Shanghai
Schizophrenia, BipolarityOtherOver 18 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia, Bipolarity